European equities are caught in a real tug-of-war, and the split says as much about time horizons as it does about fundamentals.
On the bullish side, several research notes argue the region (ex-UK) is underowned, oil tail risks are easing as US-Iran diplomacy progresses, and the global rally should broaden in the coming weeks. A separate strand of published analysis sees UK equities as a quiet AI beneficiary across industrials, financials, and healthcare.
The bearish camp leans on harder data. Institutional flow trackers show Europe seeing the heaviest regional selling among major markets, with profit resilience flagged as a worry while oil stays elevated. A more structurally cautious thread points to sticky rates, tariff risk to autos, fading PMIs, and weak consumer exposure across the Stoxx 600.
At the stock level, recent research highlights Novo Nordisk as a potential breakout on obesity-drug demand, Shell as a disappointment after trimming buybacks, European defence names as tactical sells if peace talks advance, and Siemens Energy as a structural winner from the energy transition and data-centre power demand.